Replimune Group, Inc. — Director's Dealing 2025

Apr 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2025-04-01

Reporting Person: Dhingra Kapil (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-01	Stock Option (right to buy)	$8.40	A	32000	Acquired	2035-04-01	Common Stock (32000)	Direct

Footnotes

F1: The shares underlying this option vest entirely on April 1, 2026.